SARS-CoV-2 Antibody Seroprevalence in Wuhan, China, from 23 April to 24 May 2020,mSphere

当前位置： X-MOL 学术 › mSphere › 论文详情

Our official English website, www.x-mol.net, welcomes your feedback! (Note: you will need to create a separate account there.)

SARS-CoV-2 Antibody Seroprevalence in Wuhan, China, from 23 April to 24 May 2020
mSphere ( IF 4.8 ) Pub Date : 2021-04-21 , DOI: 10.1128/msphere.01062-20
Huan Han ₁ , Junzhu Yi _{2,

3} , Gongbo Cheng ₄ , Wuhui Jiang _{2,

3} , Grzegorz M Brożek ₅ , Yingan Jiang ₆ , Chengliang Zhu ₇ , Yuchen Xia _{3,

8}

Affiliation

The outbreak of coronavirus disease 2019 (COVID-19) was first reported in Wuhan, China, in December 2019. To investigate the prevalence of COVID-19 in Wuhan, we conducted serologic tests on 35,326 individuals from four different communities to estimate cumulative incidence of infection. Our results showed that 1,332 individuals (3.77%) showed positive COVID-19 antibody (either IgM or IgG). Males had a lower positivity rate than females (3.02% versus 4.52%). The antibody positivity rates showed a clear trend of increase according to patients’ ages and varied among different communities. The results indicate that public health interventions may play important roles in the control of COVID-19.

更新日期：2021-04-21

点击分享查看原文

点击收藏

阅读更多本刊最新论文本刊介绍/投稿指南

全部期刊列表>>